{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T01:10:04Z","timestamp":1772500204521,"version":"3.50.1"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Pharm. Investig."],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s40005-022-00603-w","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T08:29:39Z","timestamp":1668760179000},"page":"269-306","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["A quality by design approach in oral extended release drug delivery systems: where we are and where we are going?"],"prefix":"10.1007","volume":"53","author":[{"given":"A. S.","family":"Sousa","sequence":"first","affiliation":[]},{"given":"J.","family":"Serra","sequence":"additional","affiliation":[]},{"given":"C.","family":"Estevens","sequence":"additional","affiliation":[]},{"given":"R.","family":"Costa","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1399-8944","authenticated-orcid":false,"given":"A. J.","family":"Ribeiro","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"key":"603_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3390\/pharmaceutics11110603","volume":"11","author":"D Abu Fara","year":"2019","unstructured":"Abu Fara D, Dadou SM, Rashid I, Al-Obeidi R, Antonijevic MD et al (2019) A direct compression matrix made from xanthan gum and low molecular weight chitosan designed to improve compressibility in controlled release tablets. Pharmaceutics 11:603","journal-title":"Pharmaceutics"},{"key":"603_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jddst.2017.06.004","volume":"42","author":"A Aguilar-De-Leyva","year":"2017","unstructured":"Aguilar-De-Leyva A, Campinez MD, Casas M, Caraballo I (2017) Design space and critical points in solid dosage forms. J Drug Deliv Sci Technol 42:134\u2013143","journal-title":"J Drug Deliv Sci Technol"},{"key":"603_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s11998-021-00536-3","volume":"19","author":"MF Akhtar","year":"2022","unstructured":"Akhtar MF, Ashraf H, Uzair M, Ahmad S, Rasul A et al (2022) Development of leachable enalapril tablets by controlled porosity osmotic pump technique; a unique approach to enhance its sustained release effect. J Coat Technol Res 19:497\u2013507","journal-title":"J Coat Technol Res"},{"key":"603_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.xphs.2016.08.026","volume":"106","author":"I Akseli","year":"2017","unstructured":"Akseli I, Xie JJ, Schultz L, Ladyzhynsky N, Bramante T et al (2017) A practical framework toward prediction of breaking force and disintegration of tablet formulations using machine learning tools. J Pharm Sci 106:234\u2013247","journal-title":"J Pharm Sci"},{"key":"603_CR5","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3109\/03639045.2012.705291","volume":"39","author":"E Aktas","year":"2013","unstructured":"Aktas E, Eroglu H, Kockan U, Oner L (2013) Systematic development of pH-independent controlled release tablets of carvedilol using central composite design and artificial neural networks. Drug Dev Ind Pharm 39:1207\u20131216","journal-title":"Drug Dev Ind Pharm"},{"key":"603_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3109\/03639045.2010.492396","volume":"37","author":"N Al-Zoubi","year":"2011","unstructured":"Al-Zoubi N, Kachrimanis K, Younis K, Malamataris S (2011) Optimization of extended-release hydrophilic matrix tablets by support vector regression. Drug Dev Ind Pharm 37:80\u201387","journal-title":"Drug Dev Ind Pharm"},{"key":"603_CR7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ijpharm.2015.08.021","volume":"494","author":"N Al-Zoubi","year":"2015","unstructured":"Al-Zoubi N, Alkhatib HS, Alobaidi G, Abdel-Rahim S, Obeidat W et al (2015) Optimization of pH-independent chronotherapeutic release of verapamil HCl from three-layer matrix tablets. Int J Pharm 494:296\u2013303","journal-title":"Int J Pharm"},{"key":"603_CR8","doi-asserted-by":"publisher","first-page":"120554","DOI":"10.1016\/j.ijpharm.2021.120554","volume":"602","author":"S Arden","year":"2021","unstructured":"Arden S, Fisher AC, Tyner K, Yu LCX, Lee SL et al (2021) Industry 4.0 for pharmaceutical manufacturing: preparing for the smart factories of the future. Int J Pharm 602:120554","journal-title":"Int J Pharm"},{"key":"603_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/B978-0-12-820045-2.00003-9","volume-title":"The era of artificial intelligence, machine learning, and data science in the pharmaceutical industry","author":"SK Ashenden","year":"2021","unstructured":"Ashenden SK, Bartosik A, Agapow P-M, Semenova E (2021) Introduction to artificial intelligence and machine learning. In: Ashenden S (ed) The era of artificial intelligence, machine learning, and data science in the pharmaceutical industry, 1st edn. Academic Press, United Kingdom, pp 15\u201326","edition":"1"},{"key":"603_CR10","doi-asserted-by":"publisher","first-page":"100758","DOI":"10.1016\/j.coche.2021.100758","volume":"34","author":"M Banner","year":"2021","unstructured":"Banner M, Alosert H, Spencer C, Cheeks M, Farid SS et al (2021) A decade in review: use of data analytics within the biopharmaceutical sector. Curr Opin Chem Eng 34:100758","journal-title":"Curr Opin Chem Eng"},{"key":"603_CR11","doi-asserted-by":"publisher","first-page":"113806","DOI":"10.1016\/j.addr.2021.05.016","volume":"175","author":"P Bannigan","year":"2021","unstructured":"Bannigan P, Aldeghi M, Bao ZQ, Hase F, Aspuru-Guzik A et al (2021) Machine learning directed drug formulation development. Adv Drug Deliv Rev 175:113806","journal-title":"Adv Drug Deliv Rev"},{"key":"603_CR12","doi-asserted-by":"publisher","first-page":"118445","DOI":"10.1016\/j.ijpharm.2019.06.036","volume":"567","author":"RV Barenji","year":"2019","unstructured":"Barenji RV, Akdag Y, Yet B, Oner L (2019) Cyber-physical-based PAT (CPbPAT) framework for Pharma 4.0. Int J Pharm 567:118445","journal-title":"Int J Pharm"},{"key":"603_CR13","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ejpb.2009.09.011","volume":"74","author":"P Barmpalexis","year":"2010","unstructured":"Barmpalexis P, Kanaze FI, Kachrimanis K, Georgarakis E (2010) Artificial neural networks in the optimization of a nimodipine controlled release tablet formulation. Eur J Pharm Biopharm 74:316\u2013323","journal-title":"Eur J Pharm Biopharm"},{"key":"603_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2018.01.052","volume":"540","author":"P Barmpalexis","year":"2018","unstructured":"Barmpalexis P, Kachrimanis K, Malamataris S (2018) Statistical moments in modelling of swelling, erosion and drug release of hydrophilic matrix-tablets. Int J Pharm 540:1\u201310","journal-title":"Int J Pharm"},{"key":"603_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijpharm.2019.04.002","volume":"563","author":"A Benedetti","year":"2019","unstructured":"Benedetti A, Khoo J, Sharma S, Facco P, Barolo M et al (2019) Data analytics on raw material properties to accelerate pharmaceutical drug development. Int J Pharm 563:122\u2013134","journal-title":"Int J Pharm"},{"key":"603_CR16","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1080\/17425247.2020.1750593","volume":"17","author":"M Bermejo","year":"2020","unstructured":"Bermejo M, Sanchez-Dengra B, Gonzalez-Alvarez M, Gonzalez-Alvarez I (2020) Oral controlled release dosage forms: dissolution versus diffusion. Expert Opin Drug Deliv 17:791\u2013803","journal-title":"Expert Opin Drug Deliv"},{"key":"603_CR17","volume-title":"Strategies to modify the drug release from pharmaceutical systems","author":"ML Bruschi","year":"2015","unstructured":"Bruschi ML (2015) Strategies to modify the drug release from pharmaceutical systems. Woodhead Publishing, United Kingdom"},{"key":"603_CR18","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1021\/mp500563n","volume":"12","author":"D Caccavo","year":"2014","unstructured":"Caccavo D, Cascone S, Lamberti G, Barba AA (2014) Modeling the drug release from hydrogel-based matrices. Mol Pharm 12:474\u2013483","journal-title":"Mol Pharm"},{"key":"603_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2478\/v10007-009-0025-8","volume":"59","author":"S Chakraborty","year":"2009","unstructured":"Chakraborty S, Khandai M, Sharma A, Patra CN, Patro VJ et al (2009) Effects of drug solubility on the release kinetics of water soluble and insoluble drugs from HPMC based matrix formulations. Acta Pharm 59:313\u2013323","journal-title":"Acta Pharm"},{"key":"603_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.15171\/apb.2019.032","volume":"9","author":"SR Chappidi","year":"2019","unstructured":"Chappidi SR, Bhargav E, Marikunte V, Chinthaginjala H, Vijaya Jyothi M et al (2019) A cost effective (QbD) approach in the development and optimization of rosiglitazone maleate mucoadhesive extended release tablets\u2014in vitro and ex vivo. Adv Pharm Bull 9:281\u2013288","journal-title":"Adv Pharm Bull"},{"key":"603_CR21","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1080\/03639045.2017.1413111","volume":"44","author":"VS Chudiwal","year":"2018","unstructured":"Chudiwal VS, Shahi S, Chudiwal S (2018) Development of sustained release gastro-retentive tablet formulation of nicardipine hydrochloride using quality by design (QbD) approach. Drug Dev Ind Pharm 44:787\u2013799","journal-title":"Drug Dev Ind Pharm"},{"key":"603_CR22","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S1461-5347(00)00269-8","volume":"3","author":"P Colombo","year":"2000","unstructured":"Colombo P, Bettini R, Santi P, Peppas NA (2000) Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. Pharm Sci Technol Today 3:198\u2013204","journal-title":"Pharm Sci Technol Today"},{"key":"603_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","volume":"13","author":"P Costa","year":"2001","unstructured":"Costa P, Manuel J, Lobo S (2001) Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13:123\u2013133","journal-title":"Eur J Pharm Sci"},{"key":"603_CR24","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ijpharm.2003.09.037","volume":"269","author":"MM Crowley","year":"2004","unstructured":"Crowley MM, Schroeder B, Fredersdorf A, Obara S, Talarico M et al (2004) Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion. Int J Pharm 269:509\u2013522","journal-title":"Int J Pharm"},{"key":"603_CR25","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/jps.24299","volume":"104","author":"VS Dave","year":"2015","unstructured":"Dave VS, Saoji SD, Raut NA, Haware RV (2015) Excipient variability and its impact on dosage form functionality. J Pharm Sci 104:906\u2013915","journal-title":"J Pharm Sci"},{"key":"603_CR26","first-page":"1","volume-title":"Pharmaceutical quality by design: a practical approach","author":"B Davis","year":"2018","unstructured":"Davis B, Schlindwein WS (2018) Introduction to quality by design (QbD). In: Schlindwein WS, Gibson M (eds) Pharmaceutical quality by design: a practical approach, 1st edn. John Wiley & Sons, United States, pp 1\u20139","edition":"1"},{"key":"603_CR27","doi-asserted-by":"publisher","DOI":"10.1109\/CTS.2013.6567203","volume-title":"Addressing big data issues in scientific data infrastructure","author":"Y Demchenko","year":"2013","unstructured":"Demchenko Y, Grosso P, de Laat C, Membrey P (2013) Addressing big data issues in scientific data infrastructure. International Conference on Collaboration Technologies and Systems (CTS), San Diego"},{"key":"603_CR28","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1208\/s12249-017-0731-3","volume":"18","author":"N Desai","year":"2017","unstructured":"Desai N, Purohit R (2017) Design and development of clopidogrel bisulfate gastroretentive osmotic formulation using quality by design tools. AAPS PharmSciTech 18:2626\u20132638","journal-title":"AAPS PharmSciTech"},{"key":"603_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s12247-021-09570-5","author":"S Diab","year":"2021","unstructured":"Diab S, Bano G, Dhenge RM, Taylor J (2021) Impact of process parameters and formulation properties on dissolution performance of an extended release tablet: a multivariate analysis. J Pharm Innov 17:892\u2013910","journal-title":"J Pharm Innov"},{"key":"603_CR30","volume-title":"Applied biopharmaceutics and pharmacokinetics","author":"H Ding","year":"2016","unstructured":"Ding H (2016) Modified-release drug products and drug devices. In: Shargel L, Yu AB (eds) Applied biopharmaceutics and pharmacokinetics, 7th edn. McGraw-Hill Education, New York","edition":"7"},{"key":"603_CR31","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3390\/pharmaceutics13050663","volume":"13","author":"J Djuris","year":"2021","unstructured":"Djuris J, Cirin-Varadjan S, Aleksic I, Djuris M, Cvijic S et al (2021) Application of machine-learning algorithms for better understanding of tableting properties of lactose co-processed with lipid excipients. Pharmaceutics 13:663","journal-title":"Pharmaceutics"},{"key":"603_CR32","unstructured":"European Medicines Agency (2012) Guideline on real time release testing (formerly guideline on parametric release). https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-real-time-release-testing-formerly-guideline-parametric-release-revision-1_en.pdf. Accessed 03 May 2022"},{"key":"603_CR33","unstructured":"European Medicines Agency (2014) Guideline on quality of oral modified release products. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-quality-oral-modified-release-products_en.pdf. Accessed 05 May 2022"},{"key":"603_CR34","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.2147\/DDDT.S278918","volume":"14","author":"S Farooqi","year":"2020","unstructured":"Farooqi S, Yousuf RI, Shoaib MH, Ahmed K, Ansar S et al (2020) Quality by design (QbD)-based numerical and graphical optimization technique for the development of osmotic pump controlled-release metoclopramide HCl tablets. Drug Des Dev Ther 14:5217\u20135234","journal-title":"Drug Des Dev Ther"},{"key":"603_CR35","first-page":"1","volume-title":"Controlled release in oral drug delivery","author":"AT Florence","year":"2011","unstructured":"Florence AT (2011) A short history of controlled drug release and an introduction. In: Wilson C, Crowley P (eds) Controlled release in oral drug delivery, 1st edn. Springer, pp 1\u201326","edition":"1"},{"key":"603_CR36","unstructured":"Food and Drug Administration (1997a) Extended release oral dosage forms: development, evaluation, and application of in vitro\/in vivo correlations. https:\/\/www.fda.gov\/media\/70939\/download. Accessed 03 May 2022"},{"key":"603_CR37","unstructured":"Food and Drug Administration (1997b) SUPAC-MR: modified release solid oral dosage forms - scale-up and postapproval changes: chemistry, manufacturing, and controls; in vitro dissolution testing and in vivo bioequivalence documentation. https:\/\/www.fda.gov\/media\/70956\/download. Accessed 03 May 2022"},{"key":"603_CR38","unstructured":"Food and Drug Administration (2004) PAT\u2014A framework for innovative pharmaceutical development, manufacturing, and quality assurance. https:\/\/www.fda.gov\/media\/71012\/download. Accessed 03 May 2022"},{"key":"603_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-4939-1519-4_2","volume-title":"Hydrophilic matrix tablets for oral controlled release","author":"JL Ford","year":"2014","unstructured":"Ford JL (2014) Design and evaluation of hydroxypropyl methylcellulose matrix tablets for oral controlled release: A historical perspective. In: Timmins P, Pygall SR, Melia CD (eds) Hydrophilic matrix tablets for oral controlled release. Springer, pp 17\u201351"},{"key":"603_CR40","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ijpharm.2010.11.030","volume":"418","author":"G Frenning","year":"2011","unstructured":"Frenning G (2011) Modelling drug release from inert matrix systems: from moving-boundary to continuous-field descriptions. Int J Pharm 418:88\u201399","journal-title":"Int J Pharm"},{"key":"603_CR41","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3390\/pharmaceutics11080400","volume":"11","author":"DL Galata","year":"2019","unstructured":"Galata DL, Farkas A, Konyves Z, Meszaros LA, Szabo E et al (2019) Fast, spectroscopy-based prediction of in vitro dissolution profile of extended release tablets using artificial neural networks. Pharmaceutics 11:400","journal-title":"Pharmaceutics"},{"key":"603_CR42","doi-asserted-by":"publisher","first-page":"120338","DOI":"10.1016\/j.ijpharm.2021.120338","volume":"597","author":"DL Galata","year":"2021","unstructured":"Galata DL, Konyves Z, Nagy B, Novak M, Meszaros LA et al (2021) Real-time release testing of dissolution based on surrogate models developed by machine learning algorithms using NIR spectra, compression force and particle size distribution as input data. Int J Pharm 597:120338","journal-title":"Int J Pharm"},{"key":"603_CR43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1515\/acph-2017-0009","volume":"67","author":"A Gavan","year":"2017","unstructured":"Gavan A, Porfire A, Marina C, Tomuta I (2017) Original research paper. Formulation and pharmaceutical development of quetiapine fumarate sustained release matrix tablets using a QbD approach. Acta Pharm 67:53\u201370","journal-title":"Acta Pharm"},{"key":"603_CR44","doi-asserted-by":"publisher","first-page":"131326","DOI":"10.1016\/j.molstruc.2021.131326","volume":"1247","author":"A Gavan","year":"2022","unstructured":"Gavan A, Sylvester B, Porfire A, Iurian S, Casian T et al (2022) NIR spectroscopy for monitoring of the critical manufacturing steps and quality attributes of paliperidone prolonged release tablets. J Mol Struct 1247:131326","journal-title":"J Mol Struct"},{"key":"603_CR45","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ijpharm.2011.09.036","volume":"421","author":"C Gendre","year":"2011","unstructured":"Gendre C, Boiret M, Genty M, Chaminade P, Pean JM (2011) Real-time predictions of drug release and end point detection of a coating operation by in-line near infrared measurements. Int J Pharm 421:237\u2013243","journal-title":"Int J Pharm"},{"key":"603_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/9781118895238.ch6","volume-title":"Pharmaceutical quality by design: a practical approach","author":"M Gibson","year":"2018","unstructured":"Gibson M, Carmody A, Weaver R (2018) Development and manufacture of drug product. In: Schlindwein WS, Gibson M (eds) Pharmaceutical quality by design: a practical approach, 1st edn. John Wiley & Sons, United States, p 117","edition":"1"},{"key":"603_CR47","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijpharm.2017.12.011","volume":"537","author":"DJ Goodwin","year":"2018","unstructured":"Goodwin DJ, van den Ban S, Denham M, Barylski I (2018) Real time release testing of tablet content and content uniformity. Int J Pharm 537:183\u2013192","journal-title":"Int J Pharm"},{"key":"603_CR48","doi-asserted-by":"publisher","first-page":"102398","DOI":"10.1016\/j.jddst.2021.102398","volume":"63","author":"B Gowthami","year":"2021","unstructured":"Gowthami B, Krishna SVG, Rao DS (2021) Formulation of tablets in capsule system: statistical optimization for chronotherapeutic drug delivery of propranolol hydrochloride. J Drug Deliv Sci Technol 63:102398","journal-title":"J Drug Deliv Sci Technol"},{"key":"603_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejpb.2019.12.007","volume":"147","author":"HB Grangeia","year":"2020","unstructured":"Grangeia HB, Silva C, Simoes SP, Reis MS (2020) Quality by design in pharmaceutical manufacturing: a systematic review of current status, challenges and future perspectives. Eur J Pharm Biopharm 147:19\u201337","journal-title":"Eur J Pharm Biopharm"},{"key":"603_CR50","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jddst.2017.04.029","volume":"39","author":"GK Guler","year":"2017","unstructured":"Guler GK, Eroglu H, Oner L (2017) Development and formulation of floating tablet formulation containing rosiglitazone maleate using Artificial neural network. J Drug Deliv Sci Technol 39:385\u2013397","journal-title":"J Drug Deliv Sci Technol"},{"key":"603_CR51","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/0008125619864925","volume":"61","author":"M Haenlein","year":"2019","unstructured":"Haenlein M, Kaplan A (2019) A brief history of artificial intelligence: on the past, present, and future of artificial intelligence. Calif Manage Rev 61:5\u201314","journal-title":"Calif Manage Rev"},{"key":"603_CR52","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ijpharm.2018.12.087","volume":"558","author":"Y Hayashi","year":"2019","unstructured":"Hayashi Y, Marumo Y, Takahashi T, Nakano Y, Kosugi A et al (2019) In silico predictions of tablet density using a quantitative structure-property relationship model. Int J Pharm 558:351\u2013356","journal-title":"Int J Pharm"},{"key":"603_CR53","doi-asserted-by":"publisher","first-page":"121158","DOI":"10.1016\/j.ijpharm.2021.121158","volume":"609","author":"Y Hayashi","year":"2021","unstructured":"Hayashi Y, Nakano Y, Marumo Y, Kumada S, Okada K et al (2021) Application of machine learning to a material library for modeling of relationships between material properties and tablet properties. Int J Pharm 609:121158","journal-title":"Int J Pharm"},{"key":"603_CR54","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1208\/s12249-014-0219-3","volume":"16","author":"J Heiman","year":"2015","unstructured":"Heiman J, Tajarobi F, Gururajan B, Juppo A, Abrahmsen-Alami S (2015) Roller compaction of hydrophilic extended release tablets-combined effects of processing variables and drug\/matrix former particle size. AAPS PharmSciTech 16:267\u2013277","journal-title":"AAPS PharmSciTech"},{"key":"603_CR55","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0168-3659(01)00410-2","volume":"76","author":"PWS Heng","year":"2001","unstructured":"Heng PWS, Chan LW, Easterbrook MG, Li XM (2001) Investigation of the influence of mean HPMC particle size and number of polymer particles on the release of aspirin from swellable hydrophilic matrix tablets. J Control Release 76:39\u201349","journal-title":"J Control Release"},{"key":"603_CR56","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1208\/s12249-008-9159-0","volume":"9","author":"PS Hiremath","year":"2008","unstructured":"Hiremath PS, Saha RN (2008) Controlled release hydrophilic matrix tablet formulations of isoniazid: design and in vitro studies. AAPS PharmSciTech 9:1171\u20131178","journal-title":"AAPS PharmSciTech"},{"key":"603_CR57","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jconrel.2008.08.012","volume":"132","author":"AS Hoffman","year":"2008","unstructured":"Hoffman AS (2008) The origins and evolution of \u201ccontrolled\u201d drug delivery systems. J Control Release 132:153\u2013163","journal-title":"J Control Release"},{"key":"603_CR58","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1208\/s12249-020-1628-0","volume":"21","author":"M Hu","year":"2020","unstructured":"Hu M, Zhu Z, Wu Y, Meng Q, Luo J et al (2020) Exploring the potential of hydrophilic matrix combined with insoluble film coating: preparation and evaluation of ambroxol hydrochloride extended release tablets. AAPS PharmSciTech 21:93","journal-title":"AAPS PharmSciTech"},{"key":"603_CR59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijpharm.2009.07.031","volume":"382","author":"J Huang","year":"2009","unstructured":"Huang J, Kaul G, Cai CS, Chatlapalli R, Hernandez-Abad P et al (2009) Quality by design case study: an integrated multivariate approach to drug product and process development. Int J Pharm 382:23\u201332","journal-title":"Int J Pharm"},{"key":"603_CR60","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1211\/jpp.59.5.0017","volume":"59","author":"S Ibric","year":"2007","unstructured":"Ibric S, Jovanovic M, Djuric Z, Parojcic J, Solomun L et al (2007) Generalized regression neural networks in prediction of drug stability. J Pharm Pharmacol 59:745\u2013750","journal-title":"J Pharm Pharmacol"},{"key":"603_CR61","unstructured":"International Conference on Harmonisation (2009) ICH guideline Q8 (R2) on pharmaceutical development. https:\/\/database.ich.org\/sites\/default\/files\/Q8_R2_Guideline.pdf. Accessed 03 May 2022"},{"key":"603_CR62","unstructured":"International Conference on Harmonisation (2010) Q8, Q9 and Q10: Questions and answers. https:\/\/database.ich.org\/sites\/default\/files\/Q8_Q9_Q10_Q%26As_R4_Q%26As_0.pdf. Accessed 06 May 2022"},{"key":"603_CR63","unstructured":"International Conference on Harmonisation (2011) Q8, Q9 and Q10: Points to consider. https:\/\/database.ich.org\/sites\/default\/files\/Q8_Q9_Q10_Q%26As_R4_Points_to_Consider_2.pdf. Accessed 06 May 2022"},{"key":"603_CR64","unstructured":"International Conference on Harmonisation (2012) ICH guideline Q11 on development and manufacture of drug substances (chemical entities and biotechnological\/biological entities). https:\/\/database.ich.org\/sites\/default\/files\/Q11%20Guideline.pdf. Accessed 03 May 2022"},{"key":"603_CR65","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ejps.2014.05.030","volume":"62","author":"M Ilic","year":"2014","unstructured":"Ilic M, Duris J, Kovacevic I, Ibric S, Parojcic J (2014) In vitro\u2014in silico\u2014in vivo drug absorption model development based on mechanistic gastrointestinal simulation and artificial neural networks: Nifedipine osmotic release tablets case study. Eur J Pharm Sci 62:212\u2013218","journal-title":"Eur J Pharm Sci"},{"key":"603_CR66","doi-asserted-by":"publisher","first-page":"481","DOI":"10.31925\/farmacia.2021.3.11","volume":"69","author":"K Ilyes","year":"2021","unstructured":"Ilyes K, Casian T, Hales D, Borodi G, Rus L et al (2021) Applying the principles of quality by design (Qbd) coupled with multivariate data analysis (MVDA) in establishing the impact of raw material variability for extended release tablets. Farmacia 69:481\u2013497","journal-title":"Farmacia"},{"key":"603_CR67","unstructured":"International Conference on Harmonisation (2005) ICH guideline Q9 on quality risk management. https:\/\/database.ich.org\/sites\/default\/files\/Q9%20Guideline.pdf. Accessed 03 May 2022"},{"key":"603_CR68","unstructured":"International Conference on Harmonisation (2008) ICH guideline Q10 on pharmaceutical quality system. https:\/\/database.ich.org\/sites\/default\/files\/Q10%20Guideline.pdf. Accessed 03 May 2022"},{"key":"603_CR69","unstructured":"International Conference on Harmonisation (2019) ICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management. https:\/\/database.ich.org\/sites\/default\/files\/Q12_Guideline_Step4_2019_1119.pdf. Accessed 03 May 2022"},{"key":"603_CR70","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s13346-014-0197-8","volume":"4","author":"MT Islam","year":"2014","unstructured":"Islam MT, Maniruzzaman M, Halsey SA, Chowdhry BZ, Douroumis D (2014) Development of sustained-release formulations processed by hot-melt extrusion by using a quality-by-design approach. Drug Deliv Transl Res 4:377\u2013387","journal-title":"Drug Deliv Transl Res"},{"key":"603_CR71","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2147\/DDDT.S125323","volume":"11","author":"S Iurian","year":"2017","unstructured":"Iurian S, Turdean L, Tomuta I (2017) Risk assessment and experimental design in the development of a prolonged release drug delivery system with paliperidone. Drug Des Dev Ther 11:733\u2013746","journal-title":"Drug Des Dev Ther"},{"key":"603_CR72","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12272-010-2232-8","volume":"33","author":"B Ivic","year":"2010","unstructured":"Ivic B, Ibric S, Betz G, Djuric Z (2010) Optimization of drug release from compressed multi unit particle system (MUPS) using generalized regression neural network (GRNN). Arch Pharm Res 33:103\u2013113","journal-title":"Arch Pharm Res"},{"key":"603_CR73","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.powtec.2020.12.044","volume":"382","author":"EH Jang","year":"2021","unstructured":"Jang EH, Park YS, Choi D (2021) Investigation of the effects of materials and dry granulation process on the mirabegron tablet by integrated QbD approach with multivariate analysis. Powder Technol 382:23\u201339","journal-title":"Powder Technol"},{"key":"603_CR74","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.2147\/DDDT.S240506","volume":"15","author":"U Kanwal","year":"2021","unstructured":"Kanwal U, Mukhtar S, Waheed M, Mehreen A, Abbas N et al (2021) Fixed dose single tablet formulation with differential release of amlodipine besylate and simvastatin and its pharmacokinetic profile: QbD and risk assessment approach. Drug Des Dev Ther 15:2193\u20132210","journal-title":"Drug Des Dev Ther"},{"key":"603_CR75","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.2147\/DDDT.S244016","volume":"14","author":"AM Khan","year":"2020","unstructured":"Khan AM, Hanif M, Bukhari NI, Shamim R, Rasool F et al (2020) Artificial neural network (ANN) approach to predict an optimized pH-dependent mesalamine matrix tablet. Drug Des Dev Ther 14:2435\u20132448","journal-title":"Drug Des Dev Ther"},{"key":"603_CR76","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3109\/03639049809082366","volume":"24","author":"CJ Kim","year":"1998","unstructured":"Kim CJ (1998) Effects of drug solubility, drug loading, and polymer molecular weight on drug release from polyox (R) tablets. Drug Dev Ind Pharm 24:645\u2013651","journal-title":"Drug Dev Ind Pharm"},{"key":"603_CR77","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/10837450.2016.1264417","volume":"23","author":"D Kosir","year":"2018","unstructured":"Kosir D, Ojstersek T, Baumgartner S, Vrecer F (2018) A study of critical functionality-related characteristics of HPMC for sustained-release tablets. Pharm Dev Technol 23:865\u2013873","journal-title":"Pharm Dev Technol"},{"key":"603_CR78","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2478\/acph-2021-0039","volume":"71","author":"B Kovacs","year":"2021","unstructured":"Kovacs B, Peterfi O, Kovacs-Deak B, Szekely-Szentmiklosi I, Fulop I et al (2021) Quality-by-design in pharmaceutical development: from current perspectives to practical applications. Acta Pharm 71:497\u2013526","journal-title":"Acta Pharm"},{"key":"603_CR79","doi-asserted-by":"publisher","first-page":"105200","DOI":"10.1016\/j.ejps.2019.105200","volume":"147","author":"J Kushner","year":"2020","unstructured":"Kushner J, Lamba M, Stock T, Wang R, Nemeth MA et al (2020) Development and validation of a Level A in vitro in vivo correlation for tofacitinib modified -release tablets using extrudable core system osmotic delivery technology. Eur J Pharm Sci 147:105200","journal-title":"Eur J Pharm Sci"},{"key":"603_CR80","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.ijpharm.2016.07.052","volume":"511","author":"S Lakio","year":"2016","unstructured":"Lakio S, Tajarobi P, Wikstrom H, Fransson M, Arnehed J et al (2016) Achieving a robust drug release from extended release tablets using an integrated continuous mixing and direct compression line. Int J Pharm 511:659\u2013668","journal-title":"Int J Pharm"},{"key":"603_CR81","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/9780470640487.ch2","volume-title":"Oral controlled release formulation design and drug delivery: theory to practice","author":"PI Lee","year":"2010","unstructured":"Lee PI, Li JX (2010) Evolution of oral controlled release dosage forms. In: Wen H, Park K (eds) Oral controlled release formulation design and drug delivery: theory to practice, 1st edn. John Wiley & Sons, New Jersey, pp 21\u201331","edition":"1"},{"key":"603_CR82","doi-asserted-by":"publisher","DOI":"10.1109\/ICASS.2018.8651985","volume-title":"Artificial neural network modeling of sustained antihypertensive drug delivery using polyelectrolyte complex based on carboxymethyl-kappa-carrageenan and chitosan as prospective carriers","author":"S Lefnaoui","year":"2018","unstructured":"Lefnaoui S, Rebouh S, Bouhedda M, Yahoum MM, Hanini S (2018) Artificial neural network modeling of sustained antihypertensive drug delivery using polyelectrolyte complex based on carboxymethyl-kappa-carrageenan and chitosan as prospective carriers. International conference on applied smart systems (ICASS), USA"},{"key":"603_CR83","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1208\/s12249-008-9060-x","volume":"9","author":"H Li","year":"2008","unstructured":"Li H, Hardy RJ, Gu X (2008) Effect of drug solubility on polymer hydration and drug dissolution from polyethylene oxide (PEO) matrix tablets. AAPS PharmSciTech 9:437\u2013443","journal-title":"AAPS PharmSciTech"},{"key":"603_CR84","doi-asserted-by":"publisher","first-page":"e0264457","DOI":"10.1371\/journal.pone.0264457","volume":"17","author":"W Lin","year":"2022","unstructured":"Lin W, Li YK, Shi QZ, Liao XR, Zeng Y et al (2022) Preparation and evaluation of bilayer-core osmotic pump tablets contained topiramate. PLoS ONE 17:e0264457","journal-title":"PLoS ONE"},{"key":"603_CR85","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ijpharm.2007.10.047","volume":"352","author":"LX Liu","year":"2008","unstructured":"Liu LX, Xu XN (2008) Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet. Int J Pharm 352:225\u2013230","journal-title":"Int J Pharm"},{"key":"603_CR86","doi-asserted-by":"publisher","first-page":"129872","DOI":"10.1016\/j.molstruc.2021.129872","volume":"1230","author":"LL Liu","year":"2021","unstructured":"Liu LL, Zhang KF, Sun ZY, Dong Q, Li L et al (2021) A new perspective in understanding the dissolution behavior of nifedipine controlled release tablets by NIR spectroscopy with aquaphotomics. J Mol Struct 1230:129872","journal-title":"J Mol Struct"},{"key":"603_CR87","first-page":"35","volume-title":"Multivariate analysis in the pharmaceutical industry","author":"JA Lopes","year":"2018","unstructured":"Lopes JA, Sarraguca MC (2018) Data processing in multivariate analysis of pharmaceutical processes. In: Ferreira A, Menezes J, Tobyn M (eds) Multivariate analysis in the pharmaceutical industry, 1st edn. Elsevier, United Kingdom, pp 35\u201351","edition":"1"},{"key":"603_CR88","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ijpharm.2018.11.039","volume":"555","author":"H Lou","year":"2019","unstructured":"Lou H, Chung JI, Kiang YH, Xiao LY, Hageman MJ (2019) The application of machine learning algorithms in understanding the effect of core\/shell technique on improving powder compactability. Int J Pharm 555:368\u2013379","journal-title":"Int J Pharm"},{"key":"603_CR89","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1016\/j.xphs.2021.04.013","volume":"110","author":"H Lou","year":"2021","unstructured":"Lou H, Lian B, Hageman MJ (2021) Applications of machine learning in solid oral dosage form development. J Pharm Sci 110:3150\u20133165","journal-title":"J Pharm Sci"},{"key":"603_CR90","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/9781118895238.ch9","volume-title":"Pharmaceutical quality by design: a practical approach","author":"L Lundsberg-Nielsen","year":"2018","unstructured":"Lundsberg-Nielsen L, Schlindwein WS, Berghaus A (2018) Process analytical technology (PAT). In: Schlindwein WS, Gibson M (eds) Pharmaceutical quality by design: a practical approach, 1st edn. John Wiley & Sons, United States, pp 227\u2013255","edition":"1"},{"key":"603_CR91","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jconrel.2011.04.002","volume":"154","author":"C Maderuelo","year":"2011","unstructured":"Maderuelo C, Zarzuelo A, Lanao JM (2011) Critical factors in the release of drugs from sustained release hydrophilic matrices. J Control Release 154:2\u201319","journal-title":"J Control Release"},{"key":"603_CR92","doi-asserted-by":"publisher","first-page":"121146","DOI":"10.1016\/j.ijpharm.2021.121146","volume":"609","author":"E Maki-Lohiluoma","year":"2021","unstructured":"Maki-Lohiluoma E, Sakkinen N, Palomaki M, Winberg O, Ta HX et al (2021) Use of machine learning in prediction of granule particle size distribution and tablet tensile strength in commercial pharmaceutical manufacturing. Int J Pharm 609:121146","journal-title":"Int J Pharm"},{"key":"603_CR93","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijpharm.2009.04.015","volume":"376","author":"V Malaterre","year":"2009","unstructured":"Malaterre V, Ogorka J, Loggia N, Gurny R (2009) Approach to design push-pull osmotic pumps. Int J Pharm 376:56\u201362","journal-title":"Int J Pharm"},{"key":"603_CR94","doi-asserted-by":"publisher","first-page":"119353","DOI":"10.1016\/j.ijpharm.2020.119353","volume":"582","author":"D Markl","year":"2020","unstructured":"Markl D, Warman M, Dumarey M, Bergman EL, Folestad S et al (2020) Review of real-time release testing of pharmaceutical tablets: state-of-the art, challenges and future perspective. Int J Pharm 582:119353","journal-title":"Int J Pharm"},{"key":"603_CR95","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s13346-016-0315-x","volume":"6","author":"AG Mirani","year":"2016","unstructured":"Mirani AG, Patankar SP, Kadam VJ (2016) Risk-based approach for systematic development of gastroretentive drug delivery system. Drug Deliv Transl Res 6:579\u2013596","journal-title":"Drug Deliv Transl Res"},{"key":"603_CR96","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1208\/s12249-013-0040-4","volume":"15","author":"S Missaghi","year":"2014","unstructured":"Missaghi S, Patel P, Farrell TP, Huatan H, Rajabi-Siahboomi AR (2014) Investigation of critical core formulation and process parameters for osmotic pump oral drug delivery. AAPS PharmSciTech 15:149\u2013160","journal-title":"AAPS PharmSciTech"},{"key":"603_CR97","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1080\/03639045.2020.1757696","volume":"46","author":"MI Mohamed","year":"2020","unstructured":"Mohamed MI, Al-Mahallawi AM, Awadalla SM (2020) Development and optimization of osmotically controlled drug delivery system for poorly aqueous soluble diacerein to improve its bioavailability. Drug Dev Ind Pharm 46:814\u2013825","journal-title":"Drug Dev Ind Pharm"},{"key":"603_CR98","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3389\/fphar.2015.00144","volume":"6","author":"MM Momin","year":"2015","unstructured":"Momin MM, Kane S, Abhang P (2015) Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride. Front Pharmacol 6:144","journal-title":"Front Pharmacol"},{"key":"603_CR99","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ejpb.2011.12.003","volume":"80","author":"J Muller","year":"2012","unstructured":"Muller J, Brock D, Knop K, Zeitler JA, Kleinebudde P (2012) Prediction of dissolution time and coating thickness of sustained release formulations using Raman spectroscopy and terahertz pulsed imaging. Eur J Pharm Biopharm 80:690\u2013697","journal-title":"Eur J Pharm Biopharm"},{"key":"603_CR100","doi-asserted-by":"publisher","first-page":"7160675","DOI":"10.1155\/2017\/7160675","volume":"2017","author":"DM Muntean","year":"2017","unstructured":"Muntean DM, Alecu C, Tomuta I (2017) Simultaneous quantification of paracetamol and caffeine in powder blends for tableting by NIR-chemometry. J Spectrosc 2017:7160675","journal-title":"J Spectrosc"},{"key":"603_CR101","doi-asserted-by":"publisher","first-page":"118464","DOI":"10.1016\/j.ijpharm.2019.118464","volume":"567","author":"B Nagy","year":"2019","unstructured":"Nagy B, Petra D, Galata DL, Demuth B, Borbas E et al (2019) Application of artificial neural networks for process analytical technology-based dissolution testing. Int J Pharm 567:118464","journal-title":"Int J Pharm"},{"key":"603_CR102","first-page":"175","volume":"2","author":"A Nokhodchi","year":"2012","unstructured":"Nokhodchi A, Raja S, Patel P, Asare-Addo K (2012) The role of oral controlled release matrix tablets in drug delivery systems. Bioimpacts 2:175\u2013187","journal-title":"Bioimpacts"},{"key":"603_CR103","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1208\/s12249-015-0301-5","volume":"16","author":"WM Obeidat","year":"2015","unstructured":"Obeidat WM, Nokhodchi A, Alkhatib H (2015) Evaluation of matrix tablets based on Eudragit\u00aeE100\/Carbopol\u00ae971P combinations for controlled release and improved compaction properties of water soluble model drug paracetamol. AAPS PharmSciTech 16:1169\u20131179","journal-title":"AAPS PharmSciTech"},{"key":"603_CR104","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/9781118895238.ch7","volume-title":"Pharmaceutical quality by design: a practical approach","author":"M Owen","year":"2018","unstructured":"Owen M, Cox I (2018) Design of experiments. In: Schlindwein WS, Gibson M (eds) Pharmaceutical quality by design: a practical approach, 1st edn. John Wiley & Sons, United States, pp 157\u2013199","edition":"1"},{"key":"603_CR105","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jddst.2018.01.008","volume":"44","author":"C Parmar","year":"2018","unstructured":"Parmar C, Parikh K, Mundada P, Bhavsar D, Sawant K (2018) Formulation and optimization of enteric coated bilayer tablets of mesalamine by RSM: In vitro\u2014In vivo investigations and roentogenographic study. J Drug Deliv Sci Technol 44:388\u2013398","journal-title":"J Drug Deliv Sci Technol"},{"key":"603_CR106","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drudis.2020.10.010","volume":"26","author":"D Paul","year":"2021","unstructured":"Paul D, Sanap G, Shenoy S, Kalyane D, Kalia K et al (2021a) Artificial intelligence in drug discovery and development. Drug Discov Today 26:80\u201393","journal-title":"Drug Discov Today"},{"key":"603_CR107","doi-asserted-by":"publisher","first-page":"120439","DOI":"10.1016\/j.ijpharm.2021.120439","volume":"599","author":"S Paul","year":"2021","unstructured":"Paul S, Baranwal Y, Tseng YC (2021b) An insight into predictive parameters of tablet capping by machine learning and multivariate tools. Int J Pharm 599:120439","journal-title":"Int J Pharm"},{"key":"603_CR108","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ijpharm.2016.08.033","volume":"512","author":"P Pawar","year":"2016","unstructured":"Pawar P, Wang YF, Keyvan G, Callegari G, Cuitino A et al (2016) Enabling real time release testing by NIR prediction of dissolution of tablets made by continuous direct compression (CDC). Int J Pharm 512:96\u2013107","journal-title":"Int J Pharm"},{"key":"603_CR109","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jconrel.2014.06.041","volume":"190","author":"NA Peppas","year":"2014","unstructured":"Peppas NA, Narasimhan B (2014) Mathematical models in drug delivery: how modeling has shaped the way we design new drug delivery systems. J Control Release 190:75\u201381","journal-title":"J Control Release"},{"key":"603_CR110","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ijpharm.2012.02.031","volume":"428","author":"J Petrovic","year":"2012","unstructured":"Petrovic J, Ibric S, Betz G, Duric Z (2012) Optimization of matrix tablets controlled drug release using Elman dynamic neural networks and decision trees. Int J Pharm 428:57\u201367","journal-title":"Int J Pharm"},{"key":"603_CR111","doi-asserted-by":"publisher","first-page":"6165","DOI":"10.1007\/s10570-019-02522-w","volume":"26","author":"M Pishnamazi","year":"2019","unstructured":"Pishnamazi M, Ismail HY, Shirazian S, Iqbal J, Walker GM et al (2019) Application of lignin in controlled release: development of predictive model based on artificial neural network for API release. Cellulose 26:6165\u20136178","journal-title":"Cellulose"},{"key":"603_CR112","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1080\/03639045.2017.1291672","volume":"43","author":"SN Politis","year":"2017","unstructured":"Politis SN, Colombo P, Colombo G (2017) Design of experiments (DoE) in pharmaceutical development. Drug Dev Ind Pharm 43:889\u2013901","journal-title":"Drug Dev Ind Pharm"},{"key":"603_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpba.2017.01.030","volume":"138","author":"A Porfire","year":"2017","unstructured":"Porfire A, Filip C, Tomuta I (2017) High-throughput NIR-chemometric methods for chemical and pharmaceutical characterization of sustained release tablets. J Pharm Biomed Anal 138:1\u201313","journal-title":"J Pharm Biomed Anal"},{"key":"603_CR114","doi-asserted-by":"publisher","first-page":"14765","DOI":"10.1038\/s41598-020-71751-y","volume":"10","author":"F Qazi","year":"2020","unstructured":"Qazi F, Shoaib MH, Yousuf RI, Siddiqui F, Nasiri MI et al (2020) QbD based Eudragit coated meclizine HCl immediate and extended release multiparticulates: formulation, characterization and pharmacokinetic evaluation using HPLC-Fluorescence detection method. Sci Rep 10:14765","journal-title":"Sci Rep"},{"key":"603_CR115","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/B978-0-12-802447-8.00019-4","volume-title":"Developing solid oral dosage forms","author":"Y Qiu","year":"2017","unstructured":"Qiu Y, Lee P (2017) Rational design of oral modified-release drug delivery systems. In: Qiu Y, Chen Y, Zhang G, Yu L, Mantri R (eds) Developing solid oral dosage forms, 2nd edn. Academic Press, London, pp 519\u2013554","edition":"2"},{"key":"603_CR116","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ijpharm.2011.02.019","volume":"417","author":"T Rajalahti","year":"2011","unstructured":"Rajalahti T, Kvalheim OM (2011) Multivariate data analysis in pharmaceutics: a tutorial review. Int J Pharm 417:280\u2013290","journal-title":"Int J Pharm"},{"key":"603_CR117","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.csbj.2019.12.006","volume":"18","author":"C Reda","year":"2020","unstructured":"Reda C, Kaufmann E, Delahaye-Duriez A (2020) Machine learning applications in drug development. Comput Struct Biotechnol J 18:241\u2013252","journal-title":"Comput Struct Biotechnol J"},{"key":"603_CR118","first-page":"100131","volume":"18","author":"IC Reinhardt","year":"2020","unstructured":"Reinhardt IC, Oliveira JC, Ring DT (2020) Current perspectives on the development of industry 4.0 in the pharmaceutical sector. J Ind Inf Integr 18:100131","journal-title":"J Ind Inf Integr"},{"key":"603_CR119","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1081\/DDC-120003007","volume":"28","author":"TD Reynolds","year":"2002","unstructured":"Reynolds TD, Mitchell SA, Balwinski KM (2002) Investigation of the effect of tablet surface area\/volume on drug release from hydroxypropylmethylcellulose controlled-release matrix tablets. Drug Dev Ind Pharm 28:457\u2013466","journal-title":"Drug Dev Ind Pharm"},{"key":"603_CR120","doi-asserted-by":"publisher","first-page":"728","DOI":"10.31925\/farmacia.2020.4.20","volume":"68","author":"LL Rus","year":"2020","unstructured":"Rus LL, Casian T, Iovanov RI, Orzea RM, Onisor I et al (2020) Quantitative characterization of sustained release tablets with diclofenac sodium by means of near-infrares spectroscopy and chemometry. Farmacia 68:728\u2013739","journal-title":"Farmacia"},{"key":"603_CR121","doi-asserted-by":"publisher","first-page":"121408","DOI":"10.1016\/j.ijpharm.2021.121408","volume":"613","author":"S Sacher","year":"2022","unstructured":"Sacher S, Poms J, Rehrl J, Khinast JG (2022) PAT implementation for advanced process control in solid dosage manufacturing-A practical guide. Int J Pharm 613:121408","journal-title":"Int J Pharm"},{"key":"603_CR122","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/10837450.2019.1684519","volume":"25","author":"MR Sanoufi","year":"2020","unstructured":"Sanoufi MR, Aljaberi A, Hamdan I, Al-Zoubi N (2020) The use of design of experiments to develop hot melt extrudates for extended release of diclofenac sodium. Pharm Dev Technol 25:187\u2013196","journal-title":"Pharm Dev Technol"},{"key":"603_CR123","doi-asserted-by":"publisher","first-page":"e18540","DOI":"10.1590\/s2175-97902019000418540","volume":"56","author":"OK Saracoglu","year":"2020","unstructured":"Saracoglu OK, Uludag MO, Ozdemir ED, Degim IT (2020) Development of controlled release dexketoprofen tablets and prediction of drug release using artificial neural network (ANN) modelling. Braz J Pharm Sci 56:e18540","journal-title":"Braz J Pharm Sci"},{"key":"603_CR124","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1080\/03639045.2018.1496450","volume":"44","author":"M Saydam","year":"2018","unstructured":"Saydam M, Takka S (2018) Development and in vitro evaluation of pH-independent release matrix tablet of weakly acidic drug valsartan using quality by design tools. Drug Dev Ind Pharm 44:1905\u20131917","journal-title":"Drug Dev Ind Pharm"},{"key":"603_CR125","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/9781118895238.ch3","volume-title":"Pharmaceutical quality by design: a practical approach","author":"S Schmitt","year":"2018","unstructured":"Schmitt S (2018) Quality systems and knowledge management. In: Schlindwein WS, Gibson M (eds) Pharmaceutical quality by design: a practical approach, 1st edn. John Wiley & Sons, United States, pp 47\u201360","edition":"1"},{"key":"603_CR126","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ijbiomac.2018.05.178","volume":"117","author":"S Sethi","year":"2018","unstructured":"Sethi S, Mangla B, Kamboj S, Rana V (2018) A QbD approach for the fabrication of immediate and prolong buoyant cinnarizine tablet using polyacrylamide-g-corn fibre gum. Int J Biol Macromol 117:350\u2013361","journal-title":"Int J Biol Macromol"},{"key":"603_CR127","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1208\/s12249-022-02225-9","volume":"23","author":"V Shah","year":"2022","unstructured":"Shah V, Khambhla E, Nivsarkar M, Trivedi R, Patel RK (2022) An Integrative QbD approach for the development and optimization of controlled release compressed coated formulation of water-soluble drugs. AAPS PharmSciTech 23:120","journal-title":"AAPS PharmSciTech"},{"key":"603_CR128","doi-asserted-by":"publisher","first-page":"8323","DOI":"10.1039\/D0RA08030F","volume":"11","author":"GL Shi","year":"2021","unstructured":"Shi GL, Lin LF, Liu YL, Chen GS, Luo YT et al (2021) Pharmaceutical application of multivariate modelling techniques: a review on the manufacturing of tablets. RSC Adv 11:8323\u20138345","journal-title":"RSC Adv"},{"key":"603_CR129","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-1-4614-0881-9_2","volume-title":"Fundamentals and applications of controlled release drug delivery","author":"RA Siegel","year":"2012","unstructured":"Siegel RA, Rathbone MJ (2012) Overview of controlled release mechanisms. In: Siepmann J, Siegel RA, Rathbone MJ (eds) Fundamentals and applications of controlled release drug delivery, 1st edn. Springer, New York, pp 19\u201343","edition":"1"},{"key":"603_CR130","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-1-4614-0881-9_7","volume-title":"Fundamentals and applications of controlled release drug delivery","author":"J Siepmann","year":"2012","unstructured":"Siepmann J, Siepmann F (2012b) Swelling controlled drug delivery systems. In: Rathbone MJ, Siepmann J, Siegel RA (eds) Fundamentals and applications of controlled release drug delivery, 1st edn. Springer, New York, pp 153\u2013170","edition":"1"},{"key":"603_CR131","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0378-5173(00)00390-2","volume":"201","author":"J Siepmann","year":"2000","unstructured":"Siepmann J, Kranz H, Peppas NA, Bodmeier R (2000) Calculation of the required size and shape of hydroxypropyl methylcellulose matrices to achieve desired drug release profiles. Int J Pharm 201:151\u2013164","journal-title":"Int J Pharm"},{"key":"603_CR132","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-1-4614-0881-9_6","volume-title":"Fundamentals and applications of controlled release drug delivery","author":"J Siepmann","year":"2012","unstructured":"Siepmann J, Siegel RA, Siepmann F (2012a) Diffusion controlled drug delivery systems. In: Rathbone MJ, Siepmann J, Siegel RA (eds) Fundamentals and applications of controlled release drug delivery, 1st edn. Springer, New York, pp 127\u2013152","edition":"1"},{"key":"603_CR133","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ejpb.2020.05.012","volume":"152","author":"MF Simoes","year":"2020","unstructured":"Simoes MF, Silva G, Pinto AC, Fonseca M, Silva NE et al (2020) Artificial neural networks applied to quality-by-design: From formulation development to clinical outcome. Eur J Pharm Biopharm 152:282\u2013295","journal-title":"Eur J Pharm Biopharm"},{"key":"603_CR134","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/9780470640487.ch17","volume-title":"Oral controlled release formulation design and drug delivery: theory to practice","author":"SK Singh","year":"2010","unstructured":"Singh SK, Venkateshwarn T, Simmons SP (2010) Oral controlled drug delivery: quality by design (QbD) approach to drug development. In: Wen H, Park K (eds) Oral controlled release formulation design and drug delivery: theory to practice, 1st edn. John Wiley & Sons, New Jersey, pp 279\u2013303","edition":"1"},{"key":"603_CR135","first-page":"48","volume":"62","author":"C Sirbu","year":"2014","unstructured":"Sirbu C, Tomuta I, Achim M, Rus LL, Vonica L et al (2014) Quantitative characterization of powder blends for tablets with Indapamide by near-infrared spectrocopy and chemometry. Farmacia 62:48\u201357","journal-title":"Farmacia"},{"key":"603_CR136","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.drudis.2019.06.005","volume":"24","author":"V Steinwandter","year":"2019","unstructured":"Steinwandter V, Borchert D, Herwig C (2019) Data science tools and applications on the way to Pharma 4.0. Drug Discov Today 24:1795\u20131805","journal-title":"Drug Discov Today"},{"key":"603_CR137","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s40005-021-00542-y","volume":"51","author":"YM Than","year":"2021","unstructured":"Than YM, Titapiwatanakun V (2021) Statistical design of experiment-based formulation development and optimization of 3D printed oral controlled release drug delivery with multi target product profile. J Pharm Investig 51:715\u2013734","journal-title":"J Pharm Investig"},{"key":"603_CR138","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/pharmaceutics10030161","volume":"10","author":"P Thapa","year":"2018","unstructured":"Thapa P, Jeong SH (2018) Effects of formulation and process variables on gastroretentive floating tablets with a high-dose soluble drug and experimental design approach. Pharmaceutics 10:161","journal-title":"Pharmaceutics"},{"key":"603_CR139","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1002\/jps.2600641218","volume":"64","author":"F Theeuwes","year":"1975","unstructured":"Theeuwes F (1975) Elementary osmotic pumps. J Pharm Sci 64:1987\u20131991","journal-title":"J Pharm Sci"},{"key":"603_CR140","doi-asserted-by":"publisher","first-page":"120049","DOI":"10.1016\/j.ijpharm.2020.120049","volume":"592","author":"S Thomas","year":"2021","unstructured":"Thomas S, Palahnuk H, Amini H, Akseli I (2021) Data-smart machine learning methods for predicting composition-dependent Young\u2019s modulus of pharmaceutical compacts. Int J Pharm 592:120049","journal-title":"Int J Pharm"},{"key":"603_CR141","doi-asserted-by":"publisher","first-page":"553","DOI":"10.4155\/tde-2016-0026","volume":"7","author":"P Timmins","year":"2016","unstructured":"Timmins P, Desai D, Chen W, Wray P, Brown J et al (2016) Advances in mechanistic understanding of release rate control mechanisms of extended-release hydrophilic matrix tablets. Ther Deliv 7:553\u2013572","journal-title":"Ther Deliv"},{"key":"603_CR142","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-1-4614-1004-1_7","volume-title":"Controlled release in oral drug delivery","author":"SB Tiwari","year":"2011","unstructured":"Tiwari SB, DiNunzio J, Rajabi-Siahboomi A (2011) Drug\u2013polymer matrices for extended release. In: Wilson CG, Crowley PJ (eds) Controlled release in oral drug delivery, 1st edn. Springer, New York, pp 131\u2013159","edition":"1"},{"key":"603_CR143","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","volume":"18","author":"J Vamathevan","year":"2019","unstructured":"Vamathevan J, Clark D, Czodrowski P, Dunham I, Ferran E et al (2019) Applications of machine learning in drug discovery and development. Nat Rev Drug Discov 18:463\u2013477","journal-title":"Nat Rev Drug Discov"},{"key":"603_CR144","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/pharmaceutics12030271","volume":"12","author":"D Van Hauwermeiren","year":"2020","unstructured":"Van Hauwermeiren D, Stock M, De Beer T, Nopens I (2020) Predicting pharmaceutical particle size distributions using kernel mean embedding. Pharmaceutics 12:271","journal-title":"Pharmaceutics"},{"key":"603_CR145","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ijpharm.2017.01.010","volume":"519","author":"B Van Snick","year":"2017","unstructured":"Van Snick B, Holman J, Cunningham C, Kumar A, Vercruysse J et al (2017) Continuous direct compression as manufacturing platform for sustained release tablets. Int J Pharm 519:390\u2013407","journal-title":"Int J Pharm"},{"key":"603_CR146","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijpharm.2016.03.058","volume":"505","author":"V Vanhoorne","year":"2016","unstructured":"Vanhoorne V, Vanbillemont B, Vercruysse J, De Leersnyder F, Gomes P et al (2016) Development of a controlled release formulation by continuous twin screw granulation: Influence of process and formulation parameters. Int J Pharm 505:61\u201368","journal-title":"Int J Pharm"},{"key":"603_CR147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10837450.2020.1808015","volume":"25","author":"JD Vanza","year":"2020","unstructured":"Vanza JD, Patel RB, Dave RR, Patel MR (2020) Polyethylene oxide and its controlled release properties in hydrophilic matrix tablets for oral administration. Pharm Dev Technol 25:1\u201319","journal-title":"Pharm Dev Technol"},{"key":"603_CR148","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0168-3659(01)00550-8","volume":"79","author":"RK Verma","year":"2002","unstructured":"Verma RK, Krishna DM, Garg S (2002) Formulation aspects in the development of osmotically controlled oral drug delivery systems. J Control Release 79:7\u201327","journal-title":"J Control Release"},{"key":"603_CR149","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.ejps.2008.11.003","volume":"36","author":"A Viriden","year":"2009","unstructured":"Viriden A, Wittgren B, Andersson T, Larsson A (2009) The effect of chemical heterogeneity of HPMC on polymer release from matrix tablets. Eur J Pharm Sci 36:392\u2013400","journal-title":"Eur J Pharm Sci"},{"key":"603_CR150","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ijpharm.2010.01.029","volume":"389","author":"A Viriden","year":"2010","unstructured":"Viriden A, Larsson A, Wittgren B (2010) The effect of substitution pattern of HPMC on polymer release from matrix tablets. Int J Pharm 389:147\u2013156","journal-title":"Int J Pharm"},{"key":"603_CR151","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ejpb.2011.02.003","volume":"78","author":"A Viriden","year":"2011","unstructured":"Viriden A, Abrahmsen-Alami S, Wittgren B, Larsson A (2011) Release of theophylline and carbamazepine from matrix tablets\u2013consequences of HPMC chemical heterogeneity. Eur J Pharm Biopharm 78:470\u2013479","journal-title":"Eur J Pharm Biopharm"},{"key":"603_CR152","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s40005-014-0170-z","volume":"45","author":"C Vora","year":"2015","unstructured":"Vora C, Patadia R, Mittal K, Mashru R (2015) Risk based approach for design and optimization of site specific delivery of isoniazid. J Pharm Investig 45:249\u2013264","journal-title":"J Pharm Investig"},{"key":"603_CR153","first-page":"131","volume-title":"Modified-release drug delivery technology","author":"RB Walker","year":"2008","unstructured":"Walker RB (2008) Modified-release delivery systems for oral use. In: Rathbone M, Hadgraft J, Roberts MS, Lane ME (eds) Modified-release drug delivery technology, 2nd edn. CRC Press, New York, pp 131\u2013141","edition":"2"},{"key":"603_CR154","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jconrel.2021.08.030","volume":"338","author":"W Wang","year":"2021","unstructured":"Wang W, Ye ZYF, Gao HL, Ouyang DF (2021) Computational pharmaceutics-A new paradigm of drug delivery. J Control Release 338:119\u2013136","journal-title":"J Control Release"},{"key":"603_CR155","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/pharmaceutics14010183","volume":"14","author":"S Wang","year":"2022","unstructured":"Wang S, Di JW, Wang D, Dai XD, Hua YB et al (2022) State-of-the-art review of artificial neural networks to predict. Characterize and optimize pharmaceutical formulation. Pharmaceutics 14:183","journal-title":"Pharmaceutics"},{"key":"603_CR156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/9780470640487","volume-title":"Oral Controlled release formulation design and drug delivery: theory to practice","author":"H Wen","year":"2010","unstructured":"Wen H, Park K (2010) Introduction and overview of oral controlled release formulation design. In: Wen H, Park K (eds) Oral Controlled release formulation design and drug delivery: theory to practice, 1st edn. John Wiley & Sons, New Jersey, pp 1\u201319","edition":"1"},{"key":"603_CR157","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/jps.23383","volume":"102","author":"M Wirges","year":"2013","unstructured":"Wirges M, Funke A, Serno P, Knop K, Kleinebudde P (2013) Monitoring of an active coating process for two-layer tablets-model development strategies. J Pharm Sci 102:556\u2013564","journal-title":"J Pharm Sci"},{"key":"603_CR158","doi-asserted-by":"publisher","first-page":"120838","DOI":"10.1016\/j.ijpharm.2021.120838","volume":"605","author":"DH Won","year":"2021","unstructured":"Won DH, Park H, Ha ES, Kim HH, Jang SW et al (2021) Optimization of bilayer tablet manufacturing process for fixed dose combination of sustained release high-dose drug and immediate release low-dose drug based on quality by design (QbD). Int J Pharm 605:120838","journal-title":"Int J Pharm"},{"key":"603_CR159","doi-asserted-by":"publisher","first-page":"6012","DOI":"10.1021\/ie504680m","volume":"54","author":"HQ Wu","year":"2015","unstructured":"Wu HQ, Lyon RC, Khan MA, Voytilla RJ, Drennen JK (2015) Integration of near-infrared spectroscopy and mechanistic modeling for predicting film-coating and dissolution of modified release tablets. Ind Eng Chem Res 54:6012\u20136023","journal-title":"Ind Eng Chem Res"},{"key":"603_CR160","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ijpharm.2016.04.061","volume":"506","author":"Y Yang","year":"2016","unstructured":"Yang Y, Zhao ZN, Wang YF, Yang L, Liu DD et al (2016) A novel asymmetric membrane osmotic pump capsule with in situ formed delivery orifices for controlled release of gliclazide solid dispersion system. Int J Pharm 506:340\u2013350","journal-title":"Int J Pharm"},{"key":"603_CR161","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.apsb.2018.09.010","volume":"9","author":"YL Yang","year":"2019","unstructured":"Yang YL, Ye ZYF, Su Y, Zhao QQ, Li XS et al (2019) Deep learning for in vitro prediction of pharmaceutical formulations. Acta Pharm Sin B 9:177\u2013185","journal-title":"Acta Pharm Sin B"},{"key":"603_CR162","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/pharmaceutics14020467","volume":"14","author":"S Yoo","year":"2022","unstructured":"Yoo S, Kim J, Choi GJ (2022) Drug properties prediction based on deep learning. Pharmaceutics 14:467","journal-title":"Pharmaceutics"},{"key":"603_CR163","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s11095-007-9511-1","volume":"25","author":"LX Yu","year":"2008","unstructured":"Yu LX (2008) Pharmaceutical quality by design: product and process development, understanding, and control. Pharm Res 25:781\u2013791","journal-title":"Pharm Res"},{"key":"603_CR164","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1208\/s12248-014-9598-3","volume":"16","author":"LX Yu","year":"2014","unstructured":"Yu LX, Amidon G, Khan MA, Hoag SW, Polli J et al (2014) Understanding pharmaceutical quality by design. AAPS J 16:771\u2013783","journal-title":"AAPS J"},{"key":"603_CR165","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejpb.2021.03.014","volume":"163","author":"JJ Yu","year":"2021","unstructured":"Yu JJ, Meng X, Dong X, Han MF, Li GT et al (2021) Synthesis and characterization of osmotic pump capsules containing polyoxyethylene and pH modifier to control the release of nifedipine. Eur J Pharm Biopharm 163:102\u2013108","journal-title":"Eur J Pharm Biopharm"},{"key":"603_CR166","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1208\/s12248-019-0297-y","volume":"21","author":"N Zaborenko","year":"2019","unstructured":"Zaborenko N, Shi Z, Corredor CC, Smith-Goettler BM, Zhang L et al (2019) First-principles and empirical approaches to predicting in vitro dissolution for pharmaceutical formulation and process development and for product release testing. AAPS J 21:32","journal-title":"AAPS J"},{"key":"603_CR167","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2016.11.004","volume":"111","author":"P Zarmpi","year":"2017","unstructured":"Zarmpi P, Flanagan T, Meehan E, Mann J, Fotaki N (2017) Biopharmaceutical aspects and implications of excipient variability in drug product performance. Eur J Pharm Biopharm 111:1\u201315","journal-title":"Eur J Pharm Biopharm"},{"key":"603_CR168","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/jps.23953","volume":"103","author":"DL Zhou","year":"2014","unstructured":"Zhou DL, Law D, Reynolds J, Davis L, Smith C et al (2014) Understanding and managing the impact of HPMC variability on drug release from controlled release formulations. J Pharm Sci 103:1664\u20131672","journal-title":"J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40005-022-00603-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40005-022-00603-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40005-022-00603-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T16:27:00Z","timestamp":1677688020000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40005-022-00603-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":168,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["603"],"URL":"https:\/\/doi.org\/10.1007\/s40005-022-00603-w","relation":{},"ISSN":["2093-5552","2093-6214"],"issn-type":[{"value":"2093-5552","type":"print"},{"value":"2093-6214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]},"assertion":[{"value":"15 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors (A.S. Sousa, J. Serra, C. Estevens, R. Costa, and A.J. Ribeiro) declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human and animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal particpants"}}]}}